HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Telmisartan/hydrochlorothiazide: in the treatment of essential hypertension.

Abstract
Oral telmisartan/hydrochlorothiazide (HCTZ) combines two antihypertensive agents, a selective angiotensin II receptor antagonist with a long half-life and once-daily administration, and a thiazide diuretic. In two large, 8-week, double-blind trials, patients with hypertension unresponsive to monotherapy who received combined telmisartan/HCTZ 80/12.5 or 40/12.5 mg/day, achieved significantly larger reductions in diastolic and systolic blood pressure (BP), than recipients of continued telmisartan monotherapy (p < 0.05 for all). Compliance with telmisartan/HCTZ 80/12.5 mg/day was 98.9%. In patients with hypertension, telmisartan/HCTZ resulted in similar BP reductions to oral enalapril/HCTZ and atenolol/HCTZ in 26-week double-blind trials and greater reductions than oral losartan/HCTZ 50/12.5 mg/day in a 6-week randomised open-label trial (p < 0.001). Up to one-third of patients with hypertension initially responsive to telmisartan 40 or 80 mg/day in a 4-year study required the eventual addition of HCTZ 12.5 or 25 mg/day and/or another agent to maintain BP control. BP was controlled in about 75% of these by adding only HCTZ. In clinical trials of up to 4 years, including elderly patients, telmisartan/HCTZ had similar tolerability to placebo, with few reports of hypokalaemia. Most adverse events were mild to moderate.
AuthorsCaroline Fenton, Gillian M Keating, Lesley J Scott
JournalDrugs (Drugs) Vol. 63 Issue 19 Pg. 2013-26; discussion 2027-8 ( 2003) ISSN: 0012-6667 [Print] New Zealand
PMID12962518 (Publication Type: Journal Article, Review)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Benzimidazoles
  • Benzoates
  • Diuretics
  • Drug Combinations
  • telmisartan, hydrochlorothiazide drug combination
  • Hydrochlorothiazide
  • Telmisartan
Topics
  • Angiotensin-Converting Enzyme Inhibitors (pharmacokinetics, pharmacology, therapeutic use)
  • Benzimidazoles (pharmacokinetics, pharmacology, therapeutic use)
  • Benzoates (pharmacokinetics, pharmacology, therapeutic use)
  • Clinical Trials as Topic
  • Diuretics (pharmacokinetics, pharmacology, therapeutic use)
  • Drug Combinations
  • Humans
  • Hydrochlorothiazide (pharmacokinetics, pharmacology, therapeutic use)
  • Hypertension (drug therapy)
  • Telmisartan

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: